These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12663049)
1. Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity. Nickolls SA; Strange PG Biochem Pharmacol; 2003 Apr; 65(7):1139-50. PubMed ID: 12663049 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological analysis of a dopamine D(2Short):G(alphao) fusion protein expressed in Sf9 cells. Gazi L; Wurch T; Lopéz-Giménez JF; Pauwels PJ; Strange PG FEBS Lett; 2003 Jun; 545(2-3):155-60. PubMed ID: 12804767 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors. Roberts DJ; Lin H; Strange PG Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865 [TBL] [Abstract][Full Text] [Related]
4. Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype. Cordeaux Y; Nickolls SA; Flood LA; Graber SG; Strange PG J Biol Chem; 2001 Aug; 276(31):28667-75. PubMed ID: 11369753 [TBL] [Abstract][Full Text] [Related]
5. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment. Geurts M; Hermans E; Maloteaux JM Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146 [TBL] [Abstract][Full Text] [Related]
6. In vivo reconstitution of dopamine D2S receptor-mediated G protein activation in baculovirus-infected insect cells: preferred coupling to Gi1 versus Gi2. Grünewald S; Reiländer H; Michel H Biochemistry; 1996 Dec; 35(48):15162-73. PubMed ID: 8952463 [TBL] [Abstract][Full Text] [Related]
7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553 [TBL] [Abstract][Full Text] [Related]
8. The influence of G protein subtype on agonist action at D2 dopamine receptors. Nickolls SA; Strange PG Neuropharmacology; 2004 Nov; 47(6):860-72. PubMed ID: 15527820 [TBL] [Abstract][Full Text] [Related]
9. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor. Pregenzer JF; Alberts GL; Im WB Neurosci Lett; 1997 Apr; 226(2):91-4. PubMed ID: 9159497 [TBL] [Abstract][Full Text] [Related]
10. Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays. Gilliland SL; Alper RH Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):498-504. PubMed ID: 10832603 [TBL] [Abstract][Full Text] [Related]
11. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Gazi L; Nickolls SA; Strange PG Br J Pharmacol; 2003 Mar; 138(5):775-86. PubMed ID: 12642378 [TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611 [TBL] [Abstract][Full Text] [Related]
13. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049 [TBL] [Abstract][Full Text] [Related]
14. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain. Sóvágó J; Makkai B; Gulyás B; Hall H Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196 [TBL] [Abstract][Full Text] [Related]
15. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation. Quirk K; Roberts DJ; Strange PG Br J Pharmacol; 2007 May; 151(1):144-52. PubMed ID: 17351658 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells. Gardner B; Hall DA; Strange PG Br J Pharmacol; 1996 Jul; 118(6):1544-50. PubMed ID: 8832084 [TBL] [Abstract][Full Text] [Related]
18. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding. Malmberg ; Mikaels ; Mohell N J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001 [TBL] [Abstract][Full Text] [Related]
19. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors. Terasmaa A; Finnman UB; Owman C; Ferré S; Fuxe K; Rinken A Neurosci Lett; 2000 Feb; 280(2):135-8. PubMed ID: 10686396 [TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes. Odagaki Y; Toyoshima R Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]